Alfasigma completes acquisition of Intercept Pharmaceuticals, Inc.

Contributed by: Business Wire

Tags

Health

Other Health

Research

Pharmaceutical

Science

Biotechnology

Intercept Pharmaceuticals, Inc.

More Like This

Alfasigma S.p.A. Tender Offer for Intercept Pharmaceuticals, Inc. Commences

Alfasigma S.p.A. Announces Expiration of Hart-Scott-Rodino Waiting Period in Connection with Pending Acquisition of Intercept Pharmaceuticals, Inc.

Vertex Enters Into Agreement to Acquire Alpine Immune Sciences

Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliary cholangitis

GENESIS Pharma Announces an Exclusive Distribution Agreement with Deciphera Pharmaceuticals to Commercialize RIPRETINIB in 14 EU Markets in Central and Eastern Europe

Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intranasal Foralumab

PR Newswire associated0

Ascentage Pharma Signs Option Agreement with Takeda to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI)

PR Newswire associated0

Ascentage Pharma Announces Closing of US$75 Million Equity Investment by Takeda